T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
101
Marsh
MRSH
$90.1B
| $1.71B | 0.18% |
9,217,878
+868,114
| +10% | +$162M |
|
102
Wabtec
WAB
$49.9B
| $1.7B | 0.18% |
7,965,503
+1,344,744
| +20% | +$276M |
|
103
Tradeweb Markets
TW
$21.9B
| $1.7B | 0.18% |
15,790,200
+2,904,984
| +23% | +$312M |
|
104
Costco
COST
$421B
| $1.68B | 0.18% |
1,953,923
+230,618
| +13% | +$209M |
|
105
Micron Technology
MU
$1.03T
| $1.67B | 0.18% |
5,852,049
-167,462
| -3% | -$38.4M |
|
|
FITB
106
Fifth Third Bancorp
FITB
$52.6B
| $1.66B | 0.18% |
35,548,204
+10,444,799
| +42% | +$460M |
|
107
IBM
IBM
$222B
| $1.66B | 0.18% |
5,617,117
+2,553,552
| +83% | +$765M |
|
108
TJX Companies
TJX
$169B
| $1.64B | 0.18% |
10,652,173
-462,968
| -4% | -$68.5M |
|
109
ASML
ASML
$695B
| $1.63B | 0.18% |
1,526,411
+193,068
| +14% | +$201M |
|
110
Valero Energy
VLO
$95.1B
| $1.63B | 0.18% |
10,024,362
-2,002,124
| -17% | -$339M |
|
111
Ametek
AME
$59.3B
| $1.62B | 0.17% |
7,892,014
-1,937,467
| -20% | -$377M |
|
112
TechnipFMC
FTI
$29.5B
| $1.62B | 0.17% |
36,302,793
-7,056,481
| -16% | -$298M |
|
113
MetLife
MET
$61.4B
| $1.6B | 0.17% |
20,233,442
-358,183
| -2% | -$28.3M |
|
114
Lowe's Companies
LOW
$121B
| $1.58B | 0.17% |
6,555,565
+2,039,343
| +45% | +$490M |
|
115
Walt Disney
DIS
$178B
| $1.58B | 0.17% |
13,876,878
+5,334,866
| +62% | +$588M |
|
116
GE Vernova
GEV
$277B
| $1.54B | 0.17% |
2,351,736
-229,533
| -9% | -$140M |
|
117
Monolithic Power Systems
MPWR
$70B
| $1.53B | 0.17% |
1,691,394
+117,596
| +7% | +$113M |
|
118
Regeneron Pharmaceuticals
REGN
$82.2B
| $1.5B | 0.16% |
1,949,797
+1,144,887
| +142% | +$778M |
|
119
Tenet Healthcare
THC
$21.5B
| $1.49B | 0.16% |
7,490,350
+119,809
| +2% | +$24.2M |
|
120
NextEra Energy
NEE
$179B
| $1.47B | 0.16% |
18,365,788
+1,136,074
| +7% | +$94.1M |
|
121
Hilton Worldwide
HLT
$72.6B
| $1.46B | 0.16% |
5,092,347
+475,896
| +10% | +$130M |
|
122
Teledyne Technologies
TDY
$31.8B
| $1.43B | 0.15% |
2,806,995
-475,674
| -14% | -$251M |
|
123
Intercontinental Exchange
ICE
$85B
| $1.42B | 0.15% |
8,738,773
+523,653
| +6% | +$82M |
|
124
American International
AIG
$39.8B
| $1.4B | 0.15% |
16,371,853
+4,661,246
| +40% | +$373M |
|
125
T. Rowe Price QM US Bond ETF
TAGG
$2.39B
| $1.4B | 0.15% |
17,945,444
+2,564,705
| +17% | +$111M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.